IFNG and type 1 diabetes mellitus: Importantly, the same splicing change could be triggered by treatment with the pro-inflammatory cytokines IL1β and IFNγ (Fig 6B), which mimic in vitro some of the pro-inflammatory conditions observed in islets of Langerhans from T1D patients (Eizirik et al, 2020).